Metastasectomy in Leiomyosarcoma: A Systematic Review and Pooled Survival Analysis

SIMPLE SUMMARY: Leiomyosarcoma (LMS) is an aggressive soft tissue sarcoma with a poor prognosis. Approximately 40% of patients will develop metastatic disease. The optimal treatment for patients with metastatic LMS is not well established, and there are no randomized controlled trials regarding meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Delisle, Megan, Alshamsan, Bader, Nagaratnam, Kalki, Smith, Denise, Wang, Ying, Srikanthan, Amirrtha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264936/
https://www.ncbi.nlm.nih.gov/pubmed/35804827
http://dx.doi.org/10.3390/cancers14133055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264936/
https://www.ncbi.nlm.nih.gov/pubmed/35804827
http://dx.doi.org/10.3390/cancers14133055

Ejemplares similares